down arrow

Balaxi Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE618N01022
  • NSEID: BALAXI
  • BSEID:
  • View on NSE
INR
25.50
1.01 (4.12%)
BSENSE

May 21

BSE+NSE Vol: 221

Access older stock analysis version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Auro Labs.
Godavari Drugs
Smruthi Organic
Lactose (India)
Brooks Lab.
Balaxi Pharma
Tyche Industries
Alpa Laboratorie
Sotac Pharma.
Krebs Biochem
Guj. Inject(Ker)

Why is Balaxi Pharmaceuticals Ltd ?

1
Weak Long Term Fundamental Strength with a -14.09% CAGR growth in Operating Profits
2
Flat results in Dec 25
  • NO KEY NEGATIVE TRIGGERS
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Balaxi Pharma for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Balaxi Pharma
-51.73%
-1.11
48.21%
Sensex
-7.48%
-0.57
12.97%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
7.72%
EBIT Growth (5y)
-14.09%
Net Debt to Equity (avg)
0.24
Institutional Holding
2.56%
ROE (avg)
25.08%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
14
Industry P/E
Price to Book Value
0.57
EV to EBIT
8.02
EV to EBITDA
7.27
EV to Capital Employed
0.60
EV to Sales
0.55
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
7.81%
ROE (Latest)
6.09%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company
Icon
NO KEY POSITIVE TRIGGERS
-1What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Download on App Store
Get it on Google Play
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."